0001973141-23-000146.txt : 20230717 0001973141-23-000146.hdr.sgml : 20230717 20230717160009 ACCESSION NUMBER: 0001973141-23-000146 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 231091638 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Olson Eric R CENTRAL INDEX KEY: 0001678149 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001678149 XXXXXXXX LIVE 0001556263 Syros Pharmaceuticals, Inc. 001-37813 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340 Olson Eric R Officer Common UBS Financial Services, Inc.

1000 Harbor Blvd 3rd Floor Weehawken NJ 07086

689 2411.50 20595503 07/17/2023 NASDAQ Common 03/31/2023 Restricted Stock Unit Issuer N 689 03/31/2023 N/A Y 07/17/2023 03/31/2023 /s/ UBS Financial Services, Inc. as attorney-in-fact for Eric Olson